Athyrium Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.48M | Hold |
1,092,976
| – | – | 63.12% | 1 |
|
|
2024
Q2 | $7.21M | Hold |
1,092,976
| – | – | 21.51% | 2 |
|
|
2024
Q1 | $12M | Hold |
1,092,976
| – | – | 16.52% | 2 |
|
|
2023
Q4 | $14.8M | Hold |
1,092,976
| – | – | 21.44% | 2 |
|
|
2023
Q3 | $23.7M | Buy |
1,092,976
+923,528
| +545% | +$20M | 20.89% | 3 |
|
|
2023
Q2 | $6.52M | Hold |
169,448
| – | – | 4.23% | 6 |
|
|
2023
Q1 | $4.69M | Hold |
169,448
| – | – | 1.68% | 8 |
|
|
2022
Q4 | $5.58M | Buy |
169,448
+50,025
| +42% | +$1.65M | 2.34% | 10 |
|
|
2022
Q3 | $14.5M | Hold |
119,423
| – | – | 5.42% | 7 |
|
|
2022
Q2 | $20.9M | Hold |
119,423
| – | – | 8.79% | 3 |
|
|
2022
Q1 | $34.6M | Hold |
119,423
| – | – | 12.31% | 3 |
|
|
2021
Q4 | $62.4M | Sell |
119,423
-26,165
| -18% | -$13.7M | 22.25% | 3 |
|
|
2021
Q3 | $55.3M | Hold |
145,588
| – | – | 35.09% | 1 |
|
|
2021
Q2 | $130M | Buy |
145,588
+37,461
| +35% | +$33.4M | 54.17% | 1 |
|
|
2021
Q1 | $129M | Hold |
108,127
| – | – | 65.06% | 1 |
|
|
2020
Q4 | $144M | Buy |
+108,127
| New | +$144M | 69.16% | 1 |
|